Solid Biosciences Inc.
SLDB· Nasdaq
Released Aug 14, 2019, before the open
10-Q filed Aug 14, 2019, 45 days after period end · 0001564590-19-031964
| Metric | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Net Income | -$26.53M | -$17.98M | -$11.31M |
| EPS Diluted | -$0.76 | -$0.52 | -$0.66 |
Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.